JMD ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/jmoldx.2008.080055 on August 7, 2008

Published online before print August 7, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jmoldx.2008.080055v1
10/5/475    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quigley, N. B.
Right arrow Articles by Press, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quigley, N. B.
Right arrow Articles by Press, R. D.
Journal of Molecular Diagnostics 2008, Vol. 10, No. 5
Copyright © 2008 American Society for Investigative Pathology & Association for Molecular Pathology
DOI: 10.2353/jmoldx.2008.080055

Correspondence

ABL Kinase Domain Pseudoexon Insertion Is Not Uncommon in BCR-ABL Transcripts

Neil B. Quigley, Donald C. Henley and Roger A. Hubbard

Molecular Pathology Laboratory Network, Inc., Marryville, Tennessee

Abstract

This Correspondence relates to "An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy" (J Mol Diagn 2008, 10:177–180).

 

Authors’ Reply:

Jennifer Laudadio

Wake Forest University, Winston-Salem, North Carolina

Richard D. Press

Oregon Health and Science University, Portland, Oregon




This article has been cited by other articles:


Home page
 J. Mol. Diagn.Home page
D. Jones, S. Kamel-Reid, D. Bahler, H. Dong, K. Elenitoba-Johnson, R. Press, N. Quigley, P. Rothberg, D. Sabath, D. Viswanatha, et al.
Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia: A Report of the Association for Molecular Pathology
J. Mol. Diagn., January 1, 2009; 11(1): 4 - 11.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology and the Association for Molecular Pathology.